source
- STAT+: Pharmalittle: We’re reading about a PhRMA ad campaign aimed at 340B, sales of Novo’s obesity pill, and moreOne of the most powerful pharmaceutical lobbying groups is launching a new seven-figure advertising blitz targeting a federal drug discount programSTAT · 3mo ago↗ source
- Consensus Viewpoints Offer Guidance in Rapidly Evolving Multiple Myeloma ManagementAjai Chari, MD, outlines key consensus viewpoints and recommendations for multiple myeloma management from Bridging the Gaps 2025.onclive · 3mo ago↗ source
- Comparing Approved Checkpoint Inhibitor Regimens and Optimal Treatment DurationNew SGO 2026 data shows frontline checkpoint inhibitors deliver 4-year survival gains and near-zero relapse after two years in DMMR cancers.